Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A population-based study on incidence, treatment, and survival in ampullary cancer in the Netherlands.
de Jong EJM, Geurts SME, van der Geest LG, Besselink MG, Bouwense SAW, Buijsen J, Dejong CHC, Heij LR, Koerkamp BG, de Hingh IHJT, Hoge C, Kazemier G, van Laarhoven HWM, de Meijer VE, Mohammad NH, Strijker M, Timmermans KCAA, Valkenburg-van Iersel LBJ, Wilmink JW, Tjan-Heijnen VCG, de Vos-Geelen J; Dutch Pancreatic Cancer Group (DPCG). de Jong EJM, et al. Among authors: strijker m. Eur J Surg Oncol. 2021 Jul;47(7):1742-1749. doi: 10.1016/j.ejso.2021.02.028. Epub 2021 Mar 6. Eur J Surg Oncol. 2021. PMID: 33712346 Free article.
Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study.
Strijker M, Belkouz A, van der Geest LG, van Gulik TM, van Hooft JE, de Meijer VE, Haj Mohammad N, de Reuver PR, Verheij J, de Vos-Geelen J, Wilmink JW, Groot Koerkamp B, Klümpen HJ, Besselink MG; Dutch Pancreatic Cancer Group. Strijker M, et al. Acta Oncol. 2019 Jul;58(7):1048-1055. doi: 10.1080/0284186X.2019.1590634. Epub 2019 Mar 25. Acta Oncol. 2019. PMID: 30907207
Readily available biomarkers predict poor survival in metastatic pancreatic cancer.
Strijker M, van Veldhuisen E, van der Geest LG, Busch OR, Bijlsma MF, Haj Mohammad N, Homs MY, van Hooft JE, Verheij J, de Vos-Geelen J, Wilmink JW, Steyerberg WEW, Besselink MG, van Laarhoven HW; Dutch Pancreatic Cancer Group. Strijker M, et al. Biomarkers. 2021 Jun;26(4):325-334. doi: 10.1080/1354750X.2021.1893814. Epub 2021 Mar 21. Biomarkers. 2021. PMID: 33663300
Preoperative serum ADAM12 levels as a stromal marker for overall survival and benefit of adjuvant therapy in patients with resected pancreatic and periampullary cancer.
Strijker M, van der Sijde F, Suker M, Boermeester MA, Bonsing BA, Bruno MJ, Busch OR, Doukas M, van Eijck CH, Gerritsen A, Groot Koerkamp B, Haj Mohammad N, van Hilst J, de Hingh IH, van Hooft JE, Luyer MD, Quintus Molenaar I, Verheij J, Waasdorp C, Wilmink JW, Besselink MG, van Laarhoven HW, Bijlsma MF; Dutch Pancreatic Cancer Group. Strijker M, et al. HPB (Oxford). 2021 Dec;23(12):1886-1896. doi: 10.1016/j.hpb.2021.05.001. Epub 2021 May 19. HPB (Oxford). 2021. PMID: 34103247 Free article.
Development and external validation of a prediction model for overall survival after resection of distal cholangiocarcinoma.
Belkouz A, Van Roessel S, Strijker M, van Dam JL, Daamen L, van der Geest LG, Balduzzi A, Cacciaguerra AB, van Dieren S, Molenaar Q, Groot Koerkamp B, Verheij J, Van Eycken E, Malleo G, Hilal MA, van Oijen MGH, Borbath I, Verslype C, Punt CJA, Besselink MG, Klümpen HJ; Dutch Pancreatic Cancer Group (DPCG). Belkouz A, et al. Among authors: strijker m. Br J Cancer. 2022 May;126(9):1280-1288. doi: 10.1038/s41416-021-01687-1. Epub 2022 Jan 17. Br J Cancer. 2022. PMID: 35039626 Free PMC article.
International validation and update of the Amsterdam model for prediction of survival after pancreatoduodenectomy for pancreatic cancer.
van Roessel S, Strijker M, Steyerberg EW, Groen JV, Mieog JS, Groot VP, He J, De Pastena M, Marchegiani G, Bassi C, Suhool A, Jang JY, Busch OR, Halimi A, Zarantonello L, Groot Koerkamp B, Samra JS, Mittal A, Gill AJ, Bolm L, van Eijck CH, Abu Hilal M, Del Chiaro M, Keck T, Alseidi A, Wolfgang CL, Malleo G, Besselink MG. van Roessel S, et al. Among authors: strijker m. Eur J Surg Oncol. 2020 May;46(5):796-803. doi: 10.1016/j.ejso.2019.12.023. Epub 2019 Dec 28. Eur J Surg Oncol. 2020. PMID: 31924432
Establishing and Coordinating a Nationwide Multidisciplinary Study Group: Lessons Learned by the Dutch Pancreatic Cancer Group.
Strijker M, Mackay TM, Bonsing BA, Bruno MJ, van Eijck CHJ, de Hingh IHJT, Koerkamp BG, van Laarhoven HW, Molenaar IQ, van Santvoort HC, van Tienhoven G, Wilmink JW, Zeverijn S, Busch OR, Besselink MG; Dutch Pancreatic Cancer Group. Strijker M, et al. Ann Surg. 2020 Apr;271(4):e102-e104. doi: 10.1097/SLA.0000000000003779. Ann Surg. 2020. PMID: 32084037 No abstract available.
Serum levels of iCAF-derived osteoglycin predict favorable outcome in pancreatic cancer.
Dings MPG, Manoukian P, Waasdorp C, Quik JSE, Strijker M, Lodestijn SC, van Neerven SM, Moreno LF, de Oliveira RL, Bonsing BA, Bruno MJ, Busch OR, Doukas M, van Eijck CH, Mohammad NH, de Hingh IH, Molenaar QI, Besselink MG, Vermeulen L, Medema JP, van Laarhoven HWM, Bijlsma MF. Dings MPG, et al. Among authors: strijker m. Int J Cancer. 2023 Feb 1;152(3):511-523. doi: 10.1002/ijc.34276. Epub 2022 Sep 19. Int J Cancer. 2023. PMID: 36069222 Free PMC article.
23 results